Pricing Log in Create free account

Assembly Biosciences, Inc. (ASMB) vs Editas Medicine, Inc. (EDIT)

Assembly Biosciences, Inc. and Editas Medicine, Inc. are both Biotechnology companies. Assembly Biosciences, Inc. and Editas Medicine, Inc. are of similar size ($405.6M and $399.3M). Assembly Biosciences, Inc. grew revenue faster over the last twelve months: 125.1% against 20.8%. Assembly Biosciences, Inc. has the higher net margin (−0.06% vs −157.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Assembly Biosciences, Inc. leads on 14 and Editas Medicine, Inc. on 1.

Valuation

Metric ASMB EDIT Biotechnology median
P/E n/m n/m 10.64
P/S 5.04 6.60 9.59
P/B 1.23 2.95 2.15
Price to free cash flow n/m n/m 26.07
EV/EBITDA n/m n/m 0.65
EV/Sales 0.76 2.79 9.45
Earnings yield (0.80%) (28.85%) (34.69%)
Free cash flow yield (10.23%) (38.78%) (24.02%)

Profitability

Metric ASMB EDIT Biotechnology median
Gross margin 100.00% 100.00% 65.59%
Operating margin (11.75%) (161.39%) 0.00%
Net margin (0.06%) (157.32%) 0.00%
Free cash flow margin (51.53%) (255.88%) 0.00%
Return on equity (0.03%) (118.82%) (51.96%)
Return on assets (0.02%) (33.02%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ASMB EDIT Biotechnology median
Revenue growth (TTM) 125.12% 20.83% 4.59%
EPS growth (last fiscal year) 91.78% 37.50% 29.88%
Revenue growth, 5-year CAGR 35.27% (14.89%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ASMB EDIT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.99 3.19 4.86
Net debt to EBITDA 17.31 0.94 1.01

Dividend

Metric ASMB EDIT Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric ASMB EDIT Biotechnology median
Market cap 405.59m 399.31m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack